Related Experiment Video
Updated: Jan 21, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Aurora kinase A promotes hepatitis B virus replication and expression
1Department of Life Sciences, Korea University, Seoul, Republic of Korea.
Abstract:
Cellular protein kinases play critical roles in various steps of the hepatitis B virus life cycle. We found that viral replication in infected or transfected hepatoma cell was markedly inhibited by treatment with A-443654, a specific inhibitor of Akt. The antiviral mechanism of the drug mainly depended on the downregulation of Aurora A, a protein kinase that plays an essential role in mitosis but has not been implicated in the viral life cycle. Our data indicated that Aurora kinase A enhances viral replication and expression independently of its kinase activity required for mitotic function. Our findings suggest that mitotic kinases, considered to be an attractive target of antitumor agents, also provide a novel target for the development of antiviral therapy.
Insights
Hepatitis B virus replication is inhibited by Akt inhibitor A-443654. This occurs through downregulating Aurora A kinase, revealing a novel target for antiviral therapy development.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Cellular protein kinases are crucial for the hepatitis B virus (HBV) life cycle.
- Akt is a key cellular protein kinase involved in various biological processes.
Purpose of the Study:
- To investigate the role of Akt and its inhibitors in hepatitis B virus replication.
- To identify novel therapeutic targets for antiviral therapy against HBV.
Main Methods:
- Treatment of infected or transfected hepatoma cells with A-443654, a specific Akt inhibitor.
- Analysis of viral replication and expression.
- Assessment of Aurora A protein kinase levels and function.
Main Results:
- A-443654 markedly inhibited hepatitis B virus replication.
- The antiviral effect was linked to the downregulation of Aurora A.
- Aurora A kinase enhances viral replication and expression independently of its mitotic kinase activity.
Conclusions:
- Akt inhibition, specifically through A-443654, demonstrates potent antiviral activity against HBV.
- Aurora A kinase represents a novel therapeutic target for developing new antiviral treatments for hepatitis B.
- Mitotic kinases, typically targeted for cancer, show potential in antiviral drug development.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
What are Viruses?
The Eukaryotic Promoter Region
Chromosome Replication
DNA Replication
Replication in Prokaryotes
DNA replication...

